Literature DB >> 12208950

The adenovirus E3 RID complex protects some cultured human T and B lymphocytes from Fas-induced apoptosis.

Adrienne L McNees1, C T Garnett, Linda R Gooding.   

Abstract

Human group C adenoviruses cause an acute infection in respiratory epithelia and establish a long-term or persistent infection, possibly in lymphocytes. The mechanism by which this persistence is maintained is unknown; however, it would require that persistently infected lymphocytes not be deleted. The adenovirus genome encodes proteins that prevent the immune system from eliminating the virus-infected cell, including the E3 receptor internalization and degradation (RID) complex. The RID complex prevents death of infected cells by blocking apoptosis initiated through death domain-containing receptors of the tumor necrosis factor receptor (TNFR) superfamily, including TNFR1 (L. R. Gooding, T. S. Ranheim, A. E. Tollefson, L. Aquino, P. Duerksen-Hughes, T. M. Horton, and W. S. Wold, J. Virol. 65:4114-4123, 1991), TNF-related apoptosis-inducing ligand receptors (TRAIL-R1 and -R2) (C. A. Benedict, P. S. Norris, T. I. Prigozy, J. L. Bodmer, J. A. Mahr, C. T. Garnett, F. Martinon, J. Tschopp, L. R. Gooding, and C. F. Ware, J. Biol. Chem. 276:3270-3278, 2001; A. E. Tollefson, K. Toth, K. Doronin, M. Kuppuswamy, O. A. Doronina, D. L. Lichtenstein, T. W. Hermiston, C. A. Smith, and W. S. Wold, J. Virol. 75:8875-8887, 2001), and Fas (J. Shisler, C. Yang, B. Walter, C. F. Ware, and L. R. Gooding, J. Virol. 71:8299-8306, 1997). Here, we test the ability of RID to protect human lymphocytes from apoptosis induced by ligation of Fas, a mechanism important for regulating lymphocyte populations. Using a retrovirus expressing RID to infect six human lymphocyte cell lines, we found that RID functions in the absence of other viral proteins to downregulate surface Fas on some, but not all, cell lines. Total cellular levels of Fas decrease as measured by Western blotting, and this loss of Fas correlates with protection from apoptosis induced by ligation of Fas in every cell line tested. Although in some cases, RID causes loss of only a fraction of surface Fas, the presence of RID completely blocks the immediate events downstream of Fas ligation (i.e., Fas-FADD association and caspase-8 cleavage) in susceptible cell lines. Nonetheless, the ability of RID to block Fas signaling is independent of the Fas signaling pathway used (type I or type II). Interestingly, among the four T-cell lines tested, RID caused loss of Fas in the two T-cell lines bearing a relatively immature phenotype, while having no activity in T cells with mature phenotypes. Collectively, these data suggest that RID functions to prevent apoptosis of some human lymphocytes by internalizing surface Fas receptors. It is possible that the expression of RID facilitates long-term infection by preventing Fas-mediated deletion of persistently infected lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208950      PMCID: PMC136506          DOI: 10.1128/jvi.76.19.9716-9723.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

Review 1.  Recognition of sorting signals by clathrin adaptors.

Authors:  R Heilker; M Spiess; P Crottet
Journal:  Bioessays       Date:  1999-07       Impact factor: 4.345

2.  E3-13.7 integral membrane proteins encoded by human adenoviruses alter epidermal growth factor receptor trafficking by interacting directly with receptors in early endosomes.

Authors:  D Crooks; S J Kil; J M McCaffery; C Carlin
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

Review 3.  Adenoviral inhibitors of apoptotic cell death.

Authors:  Adrienne L McNees; Linda R Gooding
Journal:  Virus Res       Date:  2002-09       Impact factor: 3.303

4.  The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness.

Authors:  J P Fox; C D Brandt; F E Wassermann; C E Hall; I Spigland; A Kogon; L R Elveback
Journal:  Am J Epidemiol       Date:  1969-01       Impact factor: 4.897

5.  Relationship of adenovirus to lymphocytes in naturally infected human tonsils and adenoids.

Authors:  J van der Veen; M Lambriex
Journal:  Infect Immun       Date:  1973-04       Impact factor: 3.441

6.  mRNA expression of variant Fas molecules in acute leukemia cells.

Authors:  H Inaba; Y Komada; Q S Li; X L Zhang; S Tanaka; E Azuma; H Yamamoto; M Sakurai
Journal:  Am J Hematol       Date:  1999-11       Impact factor: 10.047

7.  Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2.

Authors:  C A Benedict; P S Norris; T I Prigozy; J L Bodmer; J A Mahr; C T Garnett; F Martinon; J Tschopp; L R Gooding; C F Ware
Journal:  J Biol Chem       Date:  2000-10-24       Impact factor: 5.157

8.  Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins.

Authors:  A E Tollefson; K Toth; K Doronin; M Kuppuswamy; O A Doronina; D L Lichtenstein; T W Hermiston; C A Smith; W S Wold
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

9.  The Seattle Virus Watch. VII. Observations of adenovirus infections.

Authors:  J P Fox; C E Hall; M K Cooney
Journal:  Am J Epidemiol       Date:  1977-04       Impact factor: 4.897

10.  Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes.

Authors:  C T Garnett; D Erdman; W Xu; Linda R Gooding
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

View more
  16 in total

1.  Postinternalization inhibition of adenovirus gene expression and infectious virus production in human T-cell lines.

Authors:  Adrienne L McNees; Jeff A Mahr; David Ornelles; Linda R Gooding
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 2.  Epigenetics and the dynamics of chromatin during adenovirus infections.

Authors:  Kelsey L Lynch; Linda R Gooding; Charlie Garnett-Benson; David A Ornelles; Daphne C Avgousti
Journal:  FEBS Lett       Date:  2019-12-15       Impact factor: 4.124

3.  Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.

Authors:  Nia Tatsis; Julie C Fitzgerald; Arturo Reyes-Sandoval; Kimberly C Harris-McCoy; Scott E Hensley; Dongming Zhou; Shih-Wen Lin; Ang Bian; Zhi Quan Xiang; Amaya Iparraguirre; Cesar Lopez-Camacho; E John Wherry; Hildegund C J Ertl
Journal:  Blood       Date:  2007-05-17       Impact factor: 22.113

4.  Identification of a novel immunosubversion mechanism mediated by a virologue of the B-lymphocyte receptor TACI.

Authors:  Jason R Grant; Alexander R Moise; Wilfred A Jefferies
Journal:  Clin Vaccine Immunol       Date:  2007-05-30

5.  Homologous recombination in E3 genes of human adenovirus species D.

Authors:  Gurdeep Singh; Christopher M Robinson; Shoaleh Dehghan; Morris S Jones; David W Dyer; Donald Seto; James Chodosh
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

6.  RUNX1 permits E4orf6-directed nuclear localization of the adenovirus E1B-55K protein and associates with centers of viral DNA and RNA synthesis.

Authors:  Leslie J Marshall; Amy C Moore; Misao Ohki; Issay Kitabayashi; David Patterson; David A Ornelles
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

7.  Adenovirus Modulates Toll-Like Receptor 4 Signaling by Reprogramming ORP1L-VAP Protein Contacts for Cholesterol Transport from Endosomes to the Endoplasmic Reticulum.

Authors:  Nicholas L Cianciola; Stacey Chung; Danny Manor; Cathleen R Carlin
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

8.  Distinct domains in the adenovirus E3 RIDalpha protein are required for degradation of Fas and the epidermal growth factor receptor.

Authors:  Tom A Zanardi; Soonpin Yei; Drew L Lichtenstein; Ann E Tollefson; William S M Wold
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 9.  The battle between virus and host: modulation of Toll-like receptor signaling pathways by virus infection.

Authors:  Shin-Ichi Yokota; Tamaki Okabayashi; Nobuhiro Fujii
Journal:  Mediators Inflamm       Date:  2010-06-16       Impact factor: 4.711

10.  Adenovirus RID-alpha activates an autonomous cholesterol regulatory mechanism that rescues defects linked to Niemann-Pick disease type C.

Authors:  Nicholas L Cianciola; Cathleen R Carlin
Journal:  J Cell Biol       Date:  2009-11-16       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.